Biotech News
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
ir.tangotx.com2026-05-06 15:29 EST
BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to deliver a corporate presentation at the 44 th Annual J.P.